Spero Therapeutics | SC 13G:超过5%持股股东披露文件-Anson Funds Management LP(8.1%),Anson Management GP LLC(8.1%)等
Spero Therapeutics | 4:持股变动声明-高管 Keutzer Timothy
Spero Therapeutics | 4:持股变动声明-董事 Mahadevia Ankit
Spero Therapeutics | 4:持股变动声明-高管 JOSEPH TAMARA L
Spero Therapeutics | 4:持股变动声明-高管 HAMED KAMAL
Spero Therapeutics | 4:持股变动声明-高管 Rajavelu Esther
Spero Therapeutics | 4:持股变动声明-高管 Shukla Sath
Spero Therapeutics | 4:持股变动声明-董事 Tregoning Kathleen
Spero Therapeutics | 4:持股变动声明-高管 Rajavelu Esther
Spero Therapeutics | 3:首次持股声明-高管 Rajavelu Esther
Spero Therapeutics | 4:持股变动声明-董事 Pottage John C Jr
Spero Therapeutics | 4:持股变动声明-董事 Smith Cynthia
Spero Therapeutics | 4:持股变动声明-董事 THOMAS FRANK E
Spero Therapeutics | 4:持股变动声明-董事 Deshpande Milind
Spero Therapeutics | 4:持股变动声明-董事 Tregoning Kathleen
Spero Therapeutics | 4:持股变动声明-董事 VINK PATRICK V.J.J.
Spero Therapeutics | 4:持股变动声明-董事 Jackson Scott Thomas
Spero Therapeutics | 4:持股变动声明-董事 Mahadevia Ankit
Spero Therapeutics | 4:持股变动声明-高管 HAMED KAMAL
Spero Therapeutics | 4:持股变动声明-高管 Keutzer Timothy
暂无数据